Recovery of renal function in a dialysis-dependent patient with microscopic polyangiitis and both myeloperoxidase anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies

Internal Medicine

Volumn 50, Issue 15, 2011, Pages 1599-1603

  Mandai, Shintaro ^a   Nagahama, Kiyotaka ^b   Tsuura, Yukio ^a   Hirai, Toshiyuki ^a   Yoshioka, Wakako ^a   Takahashi, Daiei ^a   Aki, Shota ^a   Aoyagi, Makoto ^a   Tanaka, Hiroyuki ^a   Tamura, Teiichi ^a  

^a YOKOSUKA KYOSAI HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Anti GBM antibodies; HIT; Microscopic polyangiitis; MPO ANCA; RPGN

Indexed keywords

ARGATROBAN; AZATHIOPRINE; C REACTIVE PROTEIN; CREATININE; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HEPARIN; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ADULT; ANTIBODY TITER; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CATHETER THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONVALESCENCE; CREATININE BLOOD LEVEL; DIALYSIS CATHETER; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; MICROSCOPIC POLYANGIITIS; PLASMAPHERESIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; URINALYSIS; VASCULAR ACCESS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; CYCLOPHOSPHAMIDE; GLOMERULAR BASEMENT MEMBRANE; HEPARIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; MICROSCOPIC POLYANGIITIS; PEROXIDASE; PLASMA EXCHANGE; PREDNISOLONE; RENAL DIALYSIS; THROMBOCYTOPENIA;

EID: 79961196755     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4939     Document Type: Article

References (19)

1. Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 66: 1535-1540, 2004.
2. Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heer-inga P, Tervaert JW. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 46: 253-262, 2005.
3. Lindic J, Vizjak A, Ferluga D, et al. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane. Ther Apher Dial 13: 278-281, 2009.
4. Jayne DR, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18: 2180-2188, 2007.
5. de Groot K, Adu D, Savage CO. The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 16: 2018-2027, 2001.
6. Warkentin TE. Heparin-induced thrombocytopenia: Pathogenesis and management. Br J Haematol 121: 535-555, 2003.
7. Jayne DR, Marshall PD, Jones SJ, Lockwood CM. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 37: 965-970, 1990.
8. Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 8: 376-385, 1997.
9. Serratrice J, Chiche L, Dussol B, et al. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis 43: 26-30, 2004.
10. Yang R, Hellmark T, Zhao J, et al. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with Goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol 18: 1338-1343, 1997.
11. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134: 1033-1042, 2001.
12. Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies. Nephron Clin Pract 94: 59-68, 2003.
13. Bosch X, Mirapeix E, Font J, et al. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 36: 107-113, 1991.
14. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: toward consensus. Thromb Haemost 79: 1-7, 1998.
15. Yamamoto S, Koide M, Matsuo M, et al. Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 28: 82-85, 1996.
16. Syed S, Reilly RF. Heparin-induced thrombocytopenia: a renal perspective. Nat Rev Nephrol 5: 501-511, 2009.
17. Carrier M, Rodger MA, Fergusson D, et al. Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex. Kidney Int 73: 213-219, 2008.
18. Roe SD, Cassidy MJ, Haynes AP, Byrne JL. Heparin-induced thrombocytopenia (HIT) and thrombosis in a haemodialysis-dependent patient with systemic vasculitis. Nephrol Dial Transplant 13: 3226-3229, 1998.
19. Kirkland GS, Savige J, Wilson D, Heale W, Sinclair RA, Hope RN. Classical polyarteritis nodosa and microscopic polyarteritis with medium vessel involvement-a comparison of the clinical and laboratory features. Clin Nephrol 47: 176-180, 1997.